Selected research
Industry Research
NK Cell Serum-Free Medium Industry Research Report 2026
Market perspective
The global NK Cell Serum-Free Medium market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for NK Cell Serum-Free Medium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for NK Cell Serum-Free Medium is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for NK Cell Serum-Free Medium is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of NK Cell Serum-Free Medium include Fujifilm, Thermo Fisher Scientific, BioLife Solutions, Sartorius, Cytiva, WAK-Chemie Medical, Zenoaq, Merck and Vitrolife Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global NK Cell Serum-Free Medium market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
NK Cell Serum-Free Medium Market by Company
Fujifilm
Thermo Fisher Scientific
BioLife Solutions
Sartorius
Cytiva
WAK-Chemie Medical
Zenoaq
Merck
Vitrolife Group
Lifeline (ISCO)
Capricorn
BioLegend
Miltenyi Biotec
CooperSurgical
Yocon Biology
Selcell
Shanghai Epizyme
ExCell Bio
NK Cell Serum-Free Medium Segment by Type
Basic Level
Research Level
NK Cell Serum-Free Medium Segment by Application
Biotechnology Company
Universities and Research Institutes
Hospital
NK Cell Serum-Free Medium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Serum-Free Medium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NK Cell Serum-Free Medium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Serum-Free Medium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of NK Cell Serum-Free Medium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of NK Cell Serum-Free Medium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of NK Cell Serum-Free Medium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Basic Level
- Research Level
Applications
- Biotechnology Company
- Universities and Research Institutes
- Hospital
Companies covered
- Fujifilm
- Thermo Fisher Scientific
- BioLife Solutions
- Sartorius
- Cytiva
- WAK-Chemie Medical
- Zenoaq
- Merck
- Vitrolife Group
- Lifeline (ISCO)
- Capricorn
- BioLegend
- Miltenyi Biotec
- CooperSurgical
- Yocon Biology
- Selcell
- Shanghai Epizyme
- ExCell Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global NK Cell Serum-Free Medium Market Size (2021-2032)
- 2.2.2 Global NK Cell Serum-Free Medium Sales (2021-2032)
- 2.2.3 Global NK Cell Serum-Free Medium Market Average Price (2021-2032)
- 2.3 NK Cell Serum-Free Medium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Basic Level
- 2.3.3 Research Level
- 2.4 NK Cell Serum-Free Medium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Biotechnology Company
- 2.4.3 Universities and Research Institutes
- 2.4.4 Hospital
3 Market Competitive Landscape by Manufacturers
- 3.1 Global NK Cell Serum-Free Medium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global NK Cell Serum-Free Medium Sales (L) of Manufacturers (2021-2026)
- 3.3 Global NK Cell Serum-Free Medium Revenue of Manufacturers (2021-2026)
- 3.4 Global NK Cell Serum-Free Medium Average Price by Manufacturers (2021-2026)
- 3.5 Global NK Cell Serum-Free Medium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of NK Cell Serum-Free Medium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of NK Cell Serum-Free Medium, Product Type & Application
- 3.8 Global Manufacturers of NK Cell Serum-Free Medium, Established Date
- 3.9 Global NK Cell Serum-Free Medium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Fujifilm
- 4.1.1 Fujifilm Company Information
- 4.1.2 Fujifilm Business Overview
- 4.1.3 Fujifilm NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Fujifilm NK Cell Serum-Free Medium Product Portfolio
- 4.1.5 Fujifilm Recent Developments
- 4.2 Thermo Fisher Scientific
- 4.2.1 Thermo Fisher Scientific Company Information
- 4.2.2 Thermo Fisher Scientific Business Overview
- 4.2.3 Thermo Fisher Scientific NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific NK Cell Serum-Free Medium Product Portfolio
- 4.2.5 Thermo Fisher Scientific Recent Developments
- 4.3 BioLife Solutions
- 4.3.1 BioLife Solutions Company Information
- 4.3.2 BioLife Solutions Business Overview
- 4.3.3 BioLife Solutions NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BioLife Solutions NK Cell Serum-Free Medium Product Portfolio
- 4.3.5 BioLife Solutions Recent Developments
- 4.4 Sartorius
- 4.4.1 Sartorius Company Information
- 4.4.2 Sartorius Business Overview
- 4.4.3 Sartorius NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sartorius NK Cell Serum-Free Medium Product Portfolio
- 4.4.5 Sartorius Recent Developments
- 4.5 Cytiva
- 4.5.1 Cytiva Company Information
- 4.5.2 Cytiva Business Overview
- 4.5.3 Cytiva NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cytiva NK Cell Serum-Free Medium Product Portfolio
- 4.5.5 Cytiva Recent Developments
- 4.6 WAK-Chemie Medical
- 4.6.1 WAK-Chemie Medical Company Information
- 4.6.2 WAK-Chemie Medical Business Overview
- 4.6.3 WAK-Chemie Medical NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 WAK-Chemie Medical NK Cell Serum-Free Medium Product Portfolio
- 4.6.5 WAK-Chemie Medical Recent Developments
- 4.7 Zenoaq
- 4.7.1 Zenoaq Company Information
- 4.7.2 Zenoaq Business Overview
- 4.7.3 Zenoaq NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zenoaq NK Cell Serum-Free Medium Product Portfolio
- 4.7.5 Zenoaq Recent Developments
- 4.8 Merck
- 4.8.1 Merck Company Information
- 4.8.2 Merck Business Overview
- 4.8.3 Merck NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merck NK Cell Serum-Free Medium Product Portfolio
- 4.8.5 Merck Recent Developments
- 4.9 Vitrolife Group
- 4.9.1 Vitrolife Group Company Information
- 4.9.2 Vitrolife Group Business Overview
- 4.9.3 Vitrolife Group NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Vitrolife Group NK Cell Serum-Free Medium Product Portfolio
- 4.9.5 Vitrolife Group Recent Developments
- 4.10 Lifeline (ISCO)
- 4.10.1 Lifeline (ISCO) Company Information
- 4.10.2 Lifeline (ISCO) Business Overview
- 4.10.3 Lifeline (ISCO) NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lifeline (ISCO) NK Cell Serum-Free Medium Product Portfolio
- 4.10.5 Lifeline (ISCO) Recent Developments
- 4.11 Capricorn
- 4.11.1 Capricorn Company Information
- 4.11.2 Capricorn Business Overview
- 4.11.3 Capricorn NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Capricorn NK Cell Serum-Free Medium Product Portfolio
- 4.11.5 Capricorn Recent Developments
- 4.12 BioLegend
- 4.12.1 BioLegend Company Information
- 4.12.2 BioLegend Business Overview
- 4.12.3 BioLegend NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BioLegend NK Cell Serum-Free Medium Product Portfolio
- 4.12.5 BioLegend Recent Developments
- 4.13 Miltenyi Biotec
- 4.13.1 Miltenyi Biotec Company Information
- 4.13.2 Miltenyi Biotec Business Overview
- 4.13.3 Miltenyi Biotec NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Miltenyi Biotec NK Cell Serum-Free Medium Product Portfolio
- 4.13.5 Miltenyi Biotec Recent Developments
- 4.14 CooperSurgical
- 4.14.1 CooperSurgical Company Information
- 4.14.2 CooperSurgical Business Overview
- 4.14.3 CooperSurgical NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 CooperSurgical NK Cell Serum-Free Medium Product Portfolio
- 4.14.5 CooperSurgical Recent Developments
- 4.15 Yocon Biology
- 4.15.1 Yocon Biology Company Information
- 4.15.2 Yocon Biology Business Overview
- 4.15.3 Yocon Biology NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Yocon Biology NK Cell Serum-Free Medium Product Portfolio
- 4.15.5 Yocon Biology Recent Developments
- 4.16 Selcell
- 4.16.1 Selcell Company Information
- 4.16.2 Selcell Business Overview
- 4.16.3 Selcell NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Selcell NK Cell Serum-Free Medium Product Portfolio
- 4.16.5 Selcell Recent Developments
- 4.17 Shanghai Epizyme
- 4.17.1 Shanghai Epizyme Company Information
- 4.17.2 Shanghai Epizyme Business Overview
- 4.17.3 Shanghai Epizyme NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Shanghai Epizyme NK Cell Serum-Free Medium Product Portfolio
- 4.17.5 Shanghai Epizyme Recent Developments
- 4.18 ExCell Bio
- 4.18.1 ExCell Bio Company Information
- 4.18.2 ExCell Bio Business Overview
- 4.18.3 ExCell Bio NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 ExCell Bio NK Cell Serum-Free Medium Product Portfolio
- 4.18.5 ExCell Bio Recent Developments
5 Global NK Cell Serum-Free Medium Market Scenario by Region
- 5.1 Global NK Cell Serum-Free Medium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global NK Cell Serum-Free Medium Sales by Region: 2021-2032
- 5.2.1 Global NK Cell Serum-Free Medium Sales by Region: 2021-2026
- 5.2.2 Global NK Cell Serum-Free Medium Sales by Region: 2027-2032
- 5.3 Global NK Cell Serum-Free Medium Revenue by Region: 2021-2032
- 5.3.1 Global NK Cell Serum-Free Medium Revenue by Region: 2021-2026
- 5.3.2 Global NK Cell Serum-Free Medium Revenue by Region: 2027-2032
- 5.4 North America NK Cell Serum-Free Medium Market Facts & Figures by Country
- 5.4.1 North America NK Cell Serum-Free Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America NK Cell Serum-Free Medium Sales by Country (2021-2032)
- 5.4.3 North America NK Cell Serum-Free Medium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe NK Cell Serum-Free Medium Market Facts & Figures by Country
- 5.5.1 Europe NK Cell Serum-Free Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe NK Cell Serum-Free Medium Sales by Country (2021-2032)
- 5.5.3 Europe NK Cell Serum-Free Medium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific NK Cell Serum-Free Medium Market Facts & Figures by Country
- 5.6.1 Asia Pacific NK Cell Serum-Free Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific NK Cell Serum-Free Medium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific NK Cell Serum-Free Medium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America NK Cell Serum-Free Medium Market Facts & Figures by Country
- 5.7.1 South America NK Cell Serum-Free Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America NK Cell Serum-Free Medium Sales by Country (2021-2032)
- 5.7.3 South America NK Cell Serum-Free Medium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa NK Cell Serum-Free Medium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa NK Cell Serum-Free Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa NK Cell Serum-Free Medium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa NK Cell Serum-Free Medium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global NK Cell Serum-Free Medium Sales by Type (2021-2032)
- 6.1.1 Global NK Cell Serum-Free Medium Sales by Type (2021-2032) & (L)
- 6.1.2 Global NK Cell Serum-Free Medium Sales Market Share by Type (2021-2032)
- 6.2 Global NK Cell Serum-Free Medium Revenue by Type (2021-2032)
- 6.2.1 Global NK Cell Serum-Free Medium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global NK Cell Serum-Free Medium Revenue Market Share by Type (2021-2032)
- 6.3 Global NK Cell Serum-Free Medium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global NK Cell Serum-Free Medium Sales by Application (2021-2032)
- 7.1.1 Global NK Cell Serum-Free Medium Sales by Application (2021-2032) & (L)
- 7.1.2 Global NK Cell Serum-Free Medium Sales Market Share by Application (2021-2032)
- 7.2 Global NK Cell Serum-Free Medium Revenue by Application (2021-2032)
- 7.2.1 Global NK Cell Serum-Free Medium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global NK Cell Serum-Free Medium Revenue Market Share by Application (2021-2032)
- 7.3 Global NK Cell Serum-Free Medium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 NK Cell Serum-Free Medium Value Chain Analysis
- 8.1.1 NK Cell Serum-Free Medium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 NK Cell Serum-Free Medium Production Mode & Process
- 8.2 NK Cell Serum-Free Medium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 NK Cell Serum-Free Medium Distributors
- 8.2.3 NK Cell Serum-Free Medium Customers
9 Global NK Cell Serum-Free Medium Analyzing Market Dynamics
- 9.1 NK Cell Serum-Free Medium Industry Trends
- 9.2 NK Cell Serum-Free Medium Industry Drivers
- 9.3 NK Cell Serum-Free Medium Industry Opportunities and Challenges
- 9.4 NK Cell Serum-Free Medium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst